CRISPR/Cas9 gene editing appeal filed

08:50 EDT 1 Aug 2017 | CentreWatch

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics announced that The Regents of the University of California, the University of Vienna and Dr. Emmanuelle Charpentier (collectively UC), co-owners of foundational intellectual property relating to CRISPR/Cas9 genome engineering, submitted an appellate brief to the U.S. Court of Appeals for the Federal Circuit seeking reversal of […]

The post CRISPR/Cas9 gene editing appeal filed appeared first on CenterWatch News Online.

Original Article: CRISPR/Cas9 gene editing appeal filed


More From BioPortfolio on "CRISPR/Cas9 gene editing appeal filed"

Quick Search

Relevant Topic

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...